Department of Gastroenterology and Hepatology, King Abdullah Medical City, Makkah, Kingdom of Saudi Arabia.
Department of Anesthesia, King Abdullah Medical City, Makkah, Kingdom of Saudi Arabia.
Gastrointest Endosc. 2022 Dec;96(6):983-990.e2. doi: 10.1016/j.gie.2022.06.003. Epub 2022 Jun 9.
General anesthesia (GA) or monitored anesthesia care (MAC) is increasingly used to perform ERCP. The definitive choice between the 2 sedative types remains to be established. This study compared outcomes of GA with MAC in ERCP performed in patients at average risk for sedation-related adverse events (SRAEs).
At a tertiary referral center, patients with American Society of Anesthesiologists (ASA) class ≤III were randomly assigned to undergo ERCP with MAC or GA. The main outcome was a composite of hypotension, arrhythmia, hypoxia, hypercapnia, apnea, and procedural interruption or termination defined as SRAEs. In addition, ERCP procedural time, success, adverse events, and endoscopist and patient satisfaction were compared.
Of 204 randomized, 203 patients were evaluated for SRAEs (MAC, n = 96; GA, n = 107). SRAEs developed in 35% of the MAC cohort (34/96) versus 9% in the GA cohort (10/107), which was statistically significant (P < .001). Mean induction time for GA was significantly longer than that for MAC (10.3 ± 10 minutes vs 6.5 ± 10.8 minutes, respectively; P < .001). ERCP procedure time, recovery time, cannulation time and success, and procedure-related adverse events were not statistically different between the 2 sedative groups. The use of GA improved endoscopist and patient satisfaction (P < .001).
GA is safe with fewer SRAEs than MAC in patients with ASA scores ≤III undergoing ERCP. Apart from prolonging induction time, use of GA does not change the procedural success or ERCP-related adverse events and offers greater endoscopist and patient satisfaction. Hence, GA is a consideration in patients undergoing ERCP in this population group. (Clinical trial registration number: NCT04099693.).
全身麻醉(GA)或监测下麻醉管理(MAC)越来越多地用于进行 ERCP。在这两种镇静类型之间,尚未确定明确的选择。本研究比较了在镇静相关不良事件(SRAE)风险平均的患者中,GA 与 MAC 在 ERCP 中的结果。
在一家三级转诊中心,将美国麻醉医师协会(ASA)分级≤III 的患者随机分配接受 MAC 或 GA 下的 ERCP。主要结果是定义为 SRAE 的低血压、心律失常、缺氧、高碳酸血症、呼吸暂停、程序中断或终止的复合事件。此外,还比较了 ERCP 程序时间、成功率、不良事件以及内镜医生和患者满意度。
在 204 名随机分组的患者中,对 203 名患者进行了 SRAE 评估(MAC 组,n=96;GA 组,n=107)。MAC 组中 35%(34/96)发生了 SRAE,而 GA 组中 9%(10/107)发生了 SRAE,这具有统计学意义(P<0.001)。GA 的诱导时间明显长于 MAC(分别为 10.3±10 分钟和 6.5±10.8 分钟;P<0.001)。两组镇静剂之间的 ERCP 程序时间、恢复时间、插管时间和成功率以及与程序相关的不良事件无统计学差异。GA 的使用提高了内镜医生和患者的满意度(P<0.001)。
在 ASA 评分≤III 的接受 ERCP 的患者中,GA 的 SRAE 发生率低于 MAC,安全性更高。除了延长诱导时间外,GA 的使用不会改变程序成功率或 ERCP 相关不良事件,并提供更高的内镜医生和患者满意度。因此,在该人群中接受 ERCP 的患者中,GA 是一种考虑因素。(临床试验注册号:NCT04099693)。